Log In
Print
BCIQ
Print
Print this Print this
 

Fovista (formerly E10030)

  Manage Alerts
Collapse Summary General Information
Company Ophthotech Corp.
DescriptionPegylated aptamer against platelet derived growth factor B (PDGFB; PDGF2)
Molecular Target Platelet derived growth factor B (PDGFB) (PDGF2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Aptamer
Latest Stage of DevelopmentPhase III
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD); Treat wet age-related macular degeneration (AMD)
Regulatory Designation
Partner Novartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$125.0M

$200.0M

$955.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today